734 related articles for article (PubMed ID: 16944320)
1. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
Jope RS; Yuskaitis CJ; Beurel E
Neurochem Res; 2007; 32(4-5):577-95. PubMed ID: 16944320
[TBL] [Abstract][Full Text] [Related]
2. The glamour and gloom of glycogen synthase kinase-3.
Jope RS; Johnson GV
Trends Biochem Sci; 2004 Feb; 29(2):95-102. PubMed ID: 15102436
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
Jope RS; Roh MS
Curr Drug Targets; 2006 Nov; 7(11):1421-34. PubMed ID: 17100582
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3: more than a namesake.
Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A
Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2016 Jan; 107():63-81. PubMed ID: 26562543
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3 in the world of cell migration.
Sun T; Rodriguez M; Kim L
Dev Growth Differ; 2009 Dec; 51(9):735-42. PubMed ID: 19891643
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory Potential of GSK-3 Inhibitors.
Kandar CC; Sen D; Maity A
Curr Drug Targets; 2021; 22(13):1464-1476. PubMed ID: 33461462
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.
Yuskaitis CJ; Jope RS
Cell Signal; 2009 Feb; 21(2):264-73. PubMed ID: 19007880
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration.
Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Function and the Role of GSK3.
Patel S; Werstuck GH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672232
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
Beurel E; Grieco SF; Jope RS
Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes.
Beurel E; Jope RS
Neuroscience; 2010 Sep; 169(3):1063-70. PubMed ID: 20553816
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.
Wang H; Brown J; Martin M
Cytokine; 2011 Feb; 53(2):130-40. PubMed ID: 21095632
[TBL] [Abstract][Full Text] [Related]
14. GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response.
Lappas M
PLoS One; 2014; 9(12):e115854. PubMed ID: 25541965
[TBL] [Abstract][Full Text] [Related]
15. Is glycogen synthase kinase-3 a central modulator in mood regulation?
Li X; Jope RS
Neuropsychopharmacology; 2010 Oct; 35(11):2143-54. PubMed ID: 20668436
[TBL] [Abstract][Full Text] [Related]
16. Loss of glycogen synthase kinase 3 isoforms during murine oocyte growth induces offspring cardiac dysfunction.
Monteiro da Rocha A; Ding J; Slawny N; Wolf AM; Smith GD
Biol Reprod; 2015 May; 92(5):127. PubMed ID: 25833158
[TBL] [Abstract][Full Text] [Related]
17. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
[TBL] [Abstract][Full Text] [Related]
18. Implication of glycogen synthase kinase 3 in diabetes-associated islet inflammation.
Pitasi CL; Liu J; Gausserès B; Pommier G; Delangre E; Armanet M; Cattan P; Mégarbane B; Hanak AS; Maouche K; Bailbé D; Portha B; Movassat J
J Endocrinol; 2020 Jan; 244(1):133-148. PubMed ID: 31600727
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3: a drug target for CNS therapies.
Bhat RV; Budd Haeberlein SL; Avila J
J Neurochem; 2004 Jun; 89(6):1313-7. PubMed ID: 15189333
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.
Wagman AS; Johnson KW; Bussiere DE
Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
